Brief: Tetra Bio-Pharma Signs License Agreement With Thorne For A Prebiotic Dietary Supplement
22/02/2022 12:14
Feb 22 (Reuters) - Tetra Bio Pharma Inc TBP.TO :
* TETRA BIO-PHARMA SIGNS LICENSE AGREEMENT WITH THORNE FOR A
PREBIOTIC DIETARY SUPPLEMENT
* TETRA BIO PHARMA INC - AGREEMENT WILL INCLUDE ROYALTY ON
SALES
AND MILESTONE PAYMENTS
Source text for Eikon: ID:nCNW6QVYYa
Further company coverage: TBP.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding